Low dose thymoglobulin versus basiliximab in cytomegalovirus positive kidney transplant recipients: Effectiveness of preemptive cytomegalovirus modified strategy
Background: We performed a retrospective trial to determine asymptomatic CMV reactivation and CMV disease in kidney allograft recipients with positive CMV serostatus. Methods: Preemptive modified strategy under low dose thymoglobulin versus basiliximab induction was evaluated. Patients were monitore...
Główni autorzy: | , , , , , , , , , , , , , , |
---|---|
Format: | Artykuł |
Język: | Spanish |
Wydane: |
Elsevier
2023-03-01
|
Seria: | Nefrología |
Hasła przedmiotowe: | |
Dostęp online: | http://www.sciencedirect.com/science/article/pii/S0211699521002368 |